Growth hormone therapy in short stature children

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Since 1985 recombinant DNA-derived human growth hormone (hGH) became available for treatment of various growth disorders in children. GH stimulates linear growth in children with growth hormone deficiency (GHD) and also demonstrates efficacy In the treatment of Turner syndrome, chronic renal failure, Prader-Willi syndrome, and growth failure secondary to small for gestational age (SGA). Although recently FDA approved GH therapy for idiopathic short stature, the effect of GH treatment remains unclear. GH therapy is generally safe but GH has potential side effects. The decision of GH therapy in idiopathic short stature should be made individualized under consideration of the efficacy, cost-effectiveness, and psychosocial aspects, and GH therapy must be carried out by pediatric endocrinologists or experienced physicians.

Original languageEnglish
Pages (from-to)849-855
Number of pages7
JournalJournal of the Korean Medical Association
Volume51
Issue number9
DOIs
Publication statusPublished - 2008 Sep 1

Fingerprint

Growth Hormone
Therapeutics
Growth Disorders
Prader-Willi Syndrome
Turner Syndrome
Recombinant DNA
Human Growth Hormone
Growth
Gestational Age
Chronic Kidney Failure
Cost-Benefit Analysis
Pediatrics
Physicians

Keywords

  • Child
  • Efficacy
  • Growth hormone
  • Safety
  • Short stature

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Growth hormone therapy in short stature children. / Lee, Kee Hyoung.

In: Journal of the Korean Medical Association, Vol. 51, No. 9, 01.09.2008, p. 849-855.

Research output: Contribution to journalArticle

@article{60ff47d58fe54e3b817ef8b770c767d4,
title = "Growth hormone therapy in short stature children",
abstract = "Since 1985 recombinant DNA-derived human growth hormone (hGH) became available for treatment of various growth disorders in children. GH stimulates linear growth in children with growth hormone deficiency (GHD) and also demonstrates efficacy In the treatment of Turner syndrome, chronic renal failure, Prader-Willi syndrome, and growth failure secondary to small for gestational age (SGA). Although recently FDA approved GH therapy for idiopathic short stature, the effect of GH treatment remains unclear. GH therapy is generally safe but GH has potential side effects. The decision of GH therapy in idiopathic short stature should be made individualized under consideration of the efficacy, cost-effectiveness, and psychosocial aspects, and GH therapy must be carried out by pediatric endocrinologists or experienced physicians.",
keywords = "Child, Efficacy, Growth hormone, Safety, Short stature",
author = "Lee, {Kee Hyoung}",
year = "2008",
month = "9",
day = "1",
doi = "10.5124/jkma.2008.51.9.849",
language = "English",
volume = "51",
pages = "849--855",
journal = "Journal of the Korean Medical Association",
issn = "1975-8456",
publisher = "Korean Medical Association",
number = "9",

}

TY - JOUR

T1 - Growth hormone therapy in short stature children

AU - Lee, Kee Hyoung

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Since 1985 recombinant DNA-derived human growth hormone (hGH) became available for treatment of various growth disorders in children. GH stimulates linear growth in children with growth hormone deficiency (GHD) and also demonstrates efficacy In the treatment of Turner syndrome, chronic renal failure, Prader-Willi syndrome, and growth failure secondary to small for gestational age (SGA). Although recently FDA approved GH therapy for idiopathic short stature, the effect of GH treatment remains unclear. GH therapy is generally safe but GH has potential side effects. The decision of GH therapy in idiopathic short stature should be made individualized under consideration of the efficacy, cost-effectiveness, and psychosocial aspects, and GH therapy must be carried out by pediatric endocrinologists or experienced physicians.

AB - Since 1985 recombinant DNA-derived human growth hormone (hGH) became available for treatment of various growth disorders in children. GH stimulates linear growth in children with growth hormone deficiency (GHD) and also demonstrates efficacy In the treatment of Turner syndrome, chronic renal failure, Prader-Willi syndrome, and growth failure secondary to small for gestational age (SGA). Although recently FDA approved GH therapy for idiopathic short stature, the effect of GH treatment remains unclear. GH therapy is generally safe but GH has potential side effects. The decision of GH therapy in idiopathic short stature should be made individualized under consideration of the efficacy, cost-effectiveness, and psychosocial aspects, and GH therapy must be carried out by pediatric endocrinologists or experienced physicians.

KW - Child

KW - Efficacy

KW - Growth hormone

KW - Safety

KW - Short stature

UR - http://www.scopus.com/inward/record.url?scp=78649307275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649307275&partnerID=8YFLogxK

U2 - 10.5124/jkma.2008.51.9.849

DO - 10.5124/jkma.2008.51.9.849

M3 - Article

AN - SCOPUS:78649307275

VL - 51

SP - 849

EP - 855

JO - Journal of the Korean Medical Association

JF - Journal of the Korean Medical Association

SN - 1975-8456

IS - 9

ER -